BANK OF AMERICA CORP /DE/ - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$115,015
-76.6%
48,735
-37.4%
0.00%
Q2 2023$490,631
+51.2%
77,878
+38.5%
0.00%
Q1 2023$324,522
-89.3%
56,243
-81.0%
0.00%
Q4 2022$3,035,524
+171.5%
295,860
+342.3%
0.00%
Q3 2022$1,118,000
+185.9%
66,889
+139.1%
0.00%
Q2 2022$391,000
-57.7%
27,975
-51.1%
0.00%
Q1 2022$924,000
-21.4%
57,199
+4.1%
0.00%
Q4 2021$1,176,000
+152.9%
54,937
+73.7%
0.00%
Q3 2021$465,000
+266.1%
31,630
+394.1%
0.00%
Q2 2021$127,000
-80.3%
6,402
-70.4%
0.00%
Q1 2021$646,00021,6210.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders